Notice of Extraordinary General Meeting of Shareholders Regarding Share Consolidation, Abolition of the Number of Shares per Unit, and Partial Amendment of the Articles of Incorporation
Scheduled to delist on May 15, 2026. The share consolidation will consolidate 7,186,355 shares into one share, reducing the total number of issued shares from 22,535,463 to 3 shares. The tender offer price is 6,700 yen per share, and the tender offeror has already acquired 87.63% of the shares.
Notice Regarding Cancellation of Treasury Stock
Hogi Medical Co., Ltd. plans to cancel 976,397 shares of treasury stock on May 18, 2026. The cancellation is contingent upon approval of a stock consolidation at the extraordinary shareholders meeting.
Announcement Regarding the Results of the Tender Offer by TCG2509 Inc. for Our Shares and Changes in Parent Company, Major Shareholders and the Largest Major Shareholder
The tender offer by TCG2509 Inc. for 18,892,230 shares of Hogi Medical Co., Ltd. has been completed, and the company is expected to become the parent company and the largest major shareholder effective March 9, 2026.
Notice of Setting the Record Date for the Extraordinary General Meeting of Shareholders
The record date for the extraordinary general meeting of shareholders is set as March 18, 2026. This measure is taken in preparation for the privatization procedure following the successful tender offer by TCG2509 Co., Ltd. for our shares.
(Correction) Notice Regarding Correction of “Announcement of Commencement of Tender Offer for Common Shares of Hogi Medical Co., Ltd. (Securities Code: 3593) by TCG2509 Co., Ltd.”
The tender offer period by TCG2509 Co., Ltd. for shares of Hogi Medical Co., Ltd. has been extended to 40 business days from February 5, 2026, and the settlement start date has also been postponed to March 2, 2026.
(Amendment) Notice Regarding Changes to the Expression of Opinion in Support and Recommendation to Apply for the Tender Offer by TCG2509 Co., Ltd. for Shares of the Company
TCG2509 Co., Ltd. has extended the tender offer period for shares of Hogi Medical Co., Ltd. from February 5, 2026, to 40 business days (until February 20, 2026) and changed the settlement start date to March 2, 2026.
Financial Summary for the Third Quarter of Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)
For the third quarter of the fiscal year ending March 2026, net sales amounted to 28,719 million yen (4.3% decrease year-over-year), operating income was 2,088 million yen (38.7% decrease year-over-year), and quarterly net income attributable to owners of the parent was 1,438 million yen (47.4% decrease year-over-year).
Fiscal Year Ending March 2026 Q3 Financial Results Presentation
For the cumulative third quarter of the fiscal year ending March 2026, net sales were JPY 28.71 billion (95.7% YoY), operating income was JPY 2.08 billion (61.3% YoY), and net income attributable to owners of parent was JPY 1.43 billion (52.6% YoY), all showing declines.
(Correction) Notice Regarding Correction of ‘Announcement on the Commencement of Tender Offer by TCG2509 Co., Ltd. for Common Shares of Hogi Medical Co., Ltd. (Securities Code: 3593)’
In relation to the tender offer by TCG2509 Co., Ltd. for Hogi Medical Co., Ltd., the number of shares owned by GMO was corrected from 2,237,900 shares (10.38%) to 2,256,100 shares (10.46%), and on January 6, 2026, an amendment to the subscription agreement was executed.
